Coronavirus Latest News

FDA approves Pfizer booster shots for people who are ‘high risk’ or over 65

Third dose of US Covid-19 vaccine will be available for ‘healthcare workers, teachers and daycare staff and grocery workers’

The US Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer and BioNTech Covid-19 vaccine for those ages 65 and older and some high-risk Americans, paving the way for a quick rollout of the shots.

The booster dose is to be administered at least six months after completion of the second dose, and the authorization would include people most susceptible to severe disease and those in jobs that left them at risk, the FDA said.

Continue reading…

Read the original article at The Guardian

Related Articles

Back to top button